FDA final rule seeks to improve quality of data submitted on marketed devices
This article was originally published in SRA
Executive Summary
As of 1 October, medtech companies will have to provide the US Food and Drug Administration with more information on establishment registration and device listing, according to a final rule that codifies into law the agency's requirement for companies to submit registration and listing data electronically1.